EUCTR2014-004252-60-FI进行中（未招募）1 期
Shedding and immune response of rotavirus vaccine (RotaTeq) - Shedding and immune response of rotavirus vaccine (RotaTeq)
Vaccine Research Center, University of Tampere0 个研究点目标入组 250 人开始时间: 2014年11月26日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •All healthy six week old children who are born in Turku.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 250
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •- The subject has or is under suspect of immunological disorder or congenital/acquired state of immune deficiency (e.g. HIV, splenomagaly).
- •- Child is treated with immunosuppressants.
- •- Known or suspected allergy or previous serious allergic reaction caused by some ingridient of RotaTeq vaccine.
- •- Chronic illness, which might interfere taking part to this study.
- •- Child has reveiced blood transfusion or blood products including immunoglobulins.
- •- Child has already had rotavirus infection.
- •- Previous invagination.
- •- Congenital malformation of GI tract.
- •- Child is born before week 32 of pregnancy.
- •- Congenital hearth defect.
研究者
相似试验
已完成
不适用
Immune response to oral vaccinesCTRI/2012/10/003057Centre for Health Research and Development Society for Applied Studies400
进行中（未招募）
不适用
A study of the immune response to vaccination in MS patients treated with alemtuzumab - CAM-VACThe vaccinations are being used to investigate immunological memory following treatment of multiple sclerosis with the lympho-depleting humanised monoclonal antibody alemtuzumab.MedDRA version: 9.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisMedDRA version: 9.1Level: PTClassification code 10063400Term: Secondary progressive multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10046859Term: VaccinationEUCTR2009-011523-31-GBR & D, Cambridge University Hospitals60
招募中
1 期
Immune response to the recombinant Zoster Vaccine in people living with HIV over 50 years of age compared to non-HIV age- and gender-matched controls - Shingr'HIVHuman Immunodeficiency Virus (HIV)MedDRA version: 20.1Level: PTClassification code: 10020161Term: HIV infection Class: 100000004862CTIS2023-504482-23-00Centre Hospitalier Universitaire De Bordeaux225
进行中（未招募）
1 期
Immunogenicity of the Purified Vero Rabies Vaccine – Serum Free in Comparison with the Reference Purified Vero Rabies Vaccine in Pre-exposure Use in Healthy AdultsEUCTR2009-009877-85-FRSanofi Pasteur SA385
已完成
不适用
Safety and efficacy of rotavirus vaccine in infants admitting NICU; comparison between RV1 and RV5.Infants in NICJPRN-UMIN000016458Fujita Health University School of Medicine. Dept. of Pediatrics40